Before the Bell
$
30.16
Change
+0.08 +0.27%
Volume
Volume 16,441
Nov 30, 2023, 6:27 a.m.
Real time quotes
Previous close
$ 30.08
$ 30.08
Change
+0.39 +1.31%
Day low
Day high
$29.73
$30.22

52 week low
52 week high
$28.93
$54.93

Market cap
$167.64B
Average volume
29.33M
P/E ratio
16.52
Rev. per Employee
$825,759
EPS
1.82
Dividend
0.41
Div yield
5.45%
Ex dividend date
11/9/23
MarketWatch News on PFE
-
8 Beaten-Down Stocks Including Pfizer and Hasbro That Look Like Bargains
- Jacob Sonenshine
-
A Golden Age of Vaccines Is Here. What It Means for You.
- Neal Templin
-
Medicare’s exclusion of weight-loss drug coverage under fire
- Eleanor Laise
-
Why the Cheapest Stock in the S&P 500 Is No Bargain
- Jack Hough
-
Pharma's Out of Favor. 5 Drug Stocks That Can Grow.
- Josh Nathan-Kazis
-
AstraZeneca Hopes New Weight-Loss Pill Will Be a Cheaper Option
- Josh Nathan-Kazis
-
Novavax shares rise as third-quarter results top expectations
- Eleanor Laise
-
Pfizer's Weight Loss Pill Is a Do-Or-Die Milestone
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Analyst Recommendations for Teva Pharmaceutical in July
- MarketRealist.com
-
Analysts’ Latest Recommendations on Mylan
- MarketRealist.com
Other News on PFE
-
Ranking the Best Companies for Career Growth
- Lauren Weber
-
Constance Gave Me My Life Back
- Brenda Cronin
-
A Punishing Year of Thunderstorms Has Led to Record-Breaking Losses
- Richard Vanderford
-
Bayer Stock Falls On Trial Halt, Roundup Verdict
- Adrià Calatayud
-
The Covid Vaccine Windfall Turns for Pfizer and Moderna
- Allysia Finley
-
Medical Studies Are Too White. Science Aims to Get Better Data.
- Dominique Mosbergen
-
When to Get Your Covid-19, Flu and RSV Shots This Fall
- Brianna Abbott
-
S&P 500 Leads Stock Indexes Higher
- Angus Berwick
-
Never Mind Covid, Investors Want a Pfizer Obesity Pill
- David Wainer
-
Why Drug Companies Don’t Want to Sell Allergy Medicines and Bandages Anymore
- Jared S. Hopkins
-
‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon
- David Wainer
-
This $5 Billion Biotech Home Run Took Less Than a Year
- David Wainer
- Loading more headlines...
Press Releases on PFE
-
Pfizer Prices $31,000,000,000 Debt Offering
- BusinessWire - BZX
-
Pfizer Announces Proposed Notes Offering
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com